{"id":3742,"date":"2023-09-15T12:50:08","date_gmt":"2023-09-15T10:50:08","guid":{"rendered":"https:\/\/avextra.com\/?p=3742"},"modified":"2023-09-15T12:59:04","modified_gmt":"2023-09-15T10:59:04","slug":"avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria","status":"publish","type":"post","link":"https:\/\/avextra.com\/en\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/","title":{"rendered":"Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria"},"content":{"rendered":"<ul>\n<li><strong>Avextra has signed distribution agreements with two pharmaceutical distribution partners in Switzerland and one partner in Austria<\/strong><\/li>\n\n\n\n<li><strong>Avextra begins exports of standardized cannabis-based medicines from its EU-GMP German facility to its distribution partners in Switzerland and Austria<\/strong><\/li>\n\n\n\n<li><strong>The Company continues to execute on its medical cannabis focused strategy, bringing highest quality cannabis-based medicines manufactured in Germany into core European markets<\/strong><\/li>\n<\/ul>\n\n\n\n<p>BENSHEIM, Germany, Sept. 07, 2023 (GLOBE NEWSWIRE)<\/p>\n\n\n\n<p>Avextra AG (\u201c<strong>Avextra,&nbsp;<\/strong>\u201d or the \u201c<strong>Company<\/strong>\u201d), a leading vertically-integrated manufacturer of cannabis-based medicines located in Germany, is pleased to announce the signing of three long-term supply and distribution agreements. Avextra has signed distribution agreements with two leading Swiss pharmaceutical partners and one Austrian pharmaceutical distribution partner. Under the terms of the agreements, Avextra will supply its purified API Dronabinol as well as standardized cannabis extracts manufactured in its GMP facility in Germany to both Switzerland and Austria. With the necessary import permits and licenses in place, Avextra is currently executing the first export of its cannabis-based medicines into both markets, marking an important milestone in the company&#8217;s European growth strategy.<\/p>\n\n\n\n<p>Switzerland has become a spotlight market in Europe for cannabis-based medicines, with a well-established federally regulated medical cannabis access regime that continues to experience exponential growth \u2013 particularly in the extract segment. With a population of over 8 million and a large healthcare industry presence, Switzerland is one of the most innovation-friendly healthcare markets in Europe. Its regulators have been gathering experience with cannabinoid therapies for many years and the country\u2019s pragmatic approach to medical cannabis access makes it an influential market in the international context.<\/p>\n\n\n\n<p>With a slightly more conservative approach to medical cannabis access in Austria, the country has seen steady patient growth over the past five years and is now home to one of the largest populations of cannabis patients in Europe.<\/p>\n\n\n\n<p>&#8222;We are delighted to have signed these distribution agreements with some of the most respected importers in two of the fastest growing medical markets in Europe,&#8220; said Dr. Bernhard Babel, CEO of Avextra. &#8222;Switzerland and Austria are important markets for our European expansion given that regulations in both countries continue to expand access for patients and new pharmaceutical distributors begin importing. Switzerland offers a unique opportunity for us to gather important insights, understand patient needs and engage with leading clinicians and regulatory bodies. Austria\u2019s focus on licensed medicines and dronabinol falls squarely within Avextra\u2019s expertise of providing evidence-based cannabis extracts and APIs.&#8220;<\/p>\n\n\n\n<p>The latest exports to Switzerland and Austria mark the third and fourth successful exports into EU growth markets for Avextra this year. With its established business in Germany and Portugal combined with growing export activities into the UK and Italy, Avextra\u2019s cannabis-based medicines are now present in six European markets demonstrating the continued success of the Company\u2019s distribution strategy.<\/p>\n\n\n\n<h4 class=\"wp-block-heading has-primary-color has-text-color advgb-dyn-dc815efc\" id=\"\u00dcber_Avextra\" style=\"font-style:italic;font-weight:700\">About Avextra AG<\/h4>\n\n\n\n<p>Avextra is one of Europe\u2019s leading vertically integrated suppliers of high-quality Cannabis-based medicines. Founded in 2019 and based out of Germany, the company focuses on the production of precisely formulated Cannabis-based medicines. Avextra controls the entire value chain \u2013 from cultivation in Portugal to EU-GMP certified extraction and manufacturing Germany. Avextra operates across continental Europe through an expansive distribution network of multiple channels and assets strategically developed for these key markets.<\/p>\n\n\n\n<p>Learn more at avextra.com and stay up to date at LinkedIn: <a href=\"https:\/\/www.linkedin.com\/company\/avextra-ag\/\" target=\"_blank\" rel=\"noreferrer noopener\">LinkedIn.com\/company\/avextra-ag\/<\/a><\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-primary-color has-text-color advgb-dyn-f04fb5f7\" id=\"\u00dcber_Avextra\" style=\"font-style:italic;font-weight:700\">Avextra Media Enquiries:<\/h4>\n\n\n\n<p>For media enquiries or to set up an interview please contact:<\/p>\n\n\n\n<p><a href=\"mailto:press@avextra.com\">Email: press@avextra.com<\/a><\/p>\n\n\n\n<p>Phone: +49 30 408174037<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-primary-color has-text-color advgb-dyn-e51bd8d1\" id=\"Pressekontakt\" style=\"font-style:italic;font-weight:700\"><\/h4>\n\n\n\n<p class=\"has-small-font-size\">Forward-Looking Statement:<\/p>\n\n\n\n<p class=\"has-small-font-size\">This news release contains certain &#8222;forward-looking information&#8220; within the meaning of applicable securities law. A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to the risk that: synergies and expected collaboration from the event may not be fully realised or may take longer to realise than expected; consumer demand for cannabis products globally falls short of expectations; Avextra&#8217;s subsidiaries and partners are able to obtain and maintain the necessary regulatory authorizations to conduct business; and general economic, financial market, legislative, regulatory, competitive and political conditions in which Avextra and its subsidiaries and partners operate will remain the same.<\/p>\n\n\n\n<p class=\"has-small-font-size\">The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release.<\/p>","protected":false},"excerpt":{"rendered":"<p>Bensheim, 14.9.2022 \u2013 Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists\u2019 Congress in Munich from September 14 to 17, 2022\u2026<\/p>","protected":false},"author":2,"featured_media":3741,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"einzelbeitrag-ohne-bild","format":"standard","meta":{"inline_featured_image":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[8,9],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria - Cannabisbasierte Arzneimittel von Avextra<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/avextra.com\/en\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria - Cannabisbasierte Arzneimittel von Avextra\" \/>\n<meta property=\"og:description\" content=\"Bensheim, 14.9.2022 \u2013 Der f\u00fchrende Anbieter von cannabisbasierten Arzneimitteln aus Deutschland mit neuem Namen: Aus Eurox wird Avextra\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/avextra.com\/en\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/\" \/>\n<meta property=\"og:site_name\" content=\"Cannabisbasierte Arzneimittel von Avextra\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-15T10:50:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-15T10:59:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"992\" \/>\n\t<meta property=\"og:image:height\" content=\"780\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Torsten Meyer-Bautor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Torsten Meyer-Bautor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/\"},\"author\":{\"name\":\"Torsten Meyer-Bautor\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/person\/aa74df4160383edd63d06428edfecd0b\"},\"headline\":\"Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria\",\"datePublished\":\"2023-09-15T10:50:08+00:00\",\"dateModified\":\"2023-09-15T10:59:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/\"},\"wordCount\":755,\"publisher\":{\"@id\":\"https:\/\/avextra.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria.jpg\",\"articleSection\":[\"deutsch\",\"english\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/\",\"url\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/\",\"name\":\"Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria - Cannabisbasierte Arzneimittel von Avextra\",\"isPartOf\":{\"@id\":\"https:\/\/avextra.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria.jpg\",\"datePublished\":\"2023-09-15T10:50:08+00:00\",\"dateModified\":\"2023-09-15T10:59:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#primaryimage\",\"url\":\"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria.jpg\",\"contentUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria.jpg\",\"width\":992,\"height\":780},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/avextra.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/avextra.com\/#website\",\"url\":\"https:\/\/avextra.com\/\",\"name\":\"Cannabisbasierte Arzneimittel von Avextra\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/avextra.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/avextra.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/avextra.com\/#organization\",\"name\":\"Avextra Pharma GmbH\",\"url\":\"https:\/\/avextra.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg\",\"contentUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg\",\"caption\":\"Avextra Pharma GmbH\"},\"image\":{\"@id\":\"https:\/\/avextra.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/avextra-ag\/\",\"https:\/\/www.xing.com\/pages\/avextra\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/person\/aa74df4160383edd63d06428edfecd0b\",\"name\":\"Torsten Meyer-Bautor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b9ef8b21e6c420b5e45a3e65c39ed5b9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b9ef8b21e6c420b5e45a3e65c39ed5b9?s=96&d=mm&r=g\",\"caption\":\"Torsten Meyer-Bautor\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria - Cannabisbasierte Arzneimittel von Avextra","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/avextra.com\/en\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/","og_locale":"en_US","og_type":"article","og_title":"Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria - Cannabisbasierte Arzneimittel von Avextra","og_description":"Bensheim, 14.9.2022 \u2013 Der f\u00fchrende Anbieter von cannabisbasierten Arzneimitteln aus Deutschland mit neuem Namen: Aus Eurox wird Avextra\u2026","og_url":"https:\/\/avextra.com\/en\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/","og_site_name":"Cannabisbasierte Arzneimittel von Avextra","article_published_time":"2023-09-15T10:50:08+00:00","article_modified_time":"2023-09-15T10:59:04+00:00","og_image":[{"width":992,"height":780,"url":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria.jpg","type":"image\/jpeg"}],"author":"Torsten Meyer-Bautor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Torsten Meyer-Bautor","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#article","isPartOf":{"@id":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/"},"author":{"name":"Torsten Meyer-Bautor","@id":"https:\/\/avextra.com\/#\/schema\/person\/aa74df4160383edd63d06428edfecd0b"},"headline":"Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria","datePublished":"2023-09-15T10:50:08+00:00","dateModified":"2023-09-15T10:59:04+00:00","mainEntityOfPage":{"@id":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/"},"wordCount":755,"publisher":{"@id":"https:\/\/avextra.com\/#organization"},"image":{"@id":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#primaryimage"},"thumbnailUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria.jpg","articleSection":["deutsch","english"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/","url":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/","name":"Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria - Cannabisbasierte Arzneimittel von Avextra","isPartOf":{"@id":"https:\/\/avextra.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#primaryimage"},"image":{"@id":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#primaryimage"},"thumbnailUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria.jpg","datePublished":"2023-09-15T10:50:08+00:00","dateModified":"2023-09-15T10:59:04+00:00","breadcrumb":{"@id":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#primaryimage","url":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria.jpg","contentUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria.jpg","width":992,"height":780},{"@type":"BreadcrumbList","@id":"https:\/\/avextra.com\/2023\/09\/avextra-signs-distribution-agreements-with-pharmaceutical-partners-and-commences-exports-of-cannabis-based-medicines-to-switzerland-and-austria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/avextra.com\/"},{"@type":"ListItem","position":2,"name":"Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria"}]},{"@type":"WebSite","@id":"https:\/\/avextra.com\/#website","url":"https:\/\/avextra.com\/","name":"Cannabisbasierte Arzneimittel von Avextra","description":"","publisher":{"@id":"https:\/\/avextra.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/avextra.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/avextra.com\/#organization","name":"Avextra Pharma GmbH","url":"https:\/\/avextra.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/avextra.com\/#\/schema\/logo\/image\/","url":"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg","contentUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg","caption":"Avextra Pharma GmbH"},"image":{"@id":"https:\/\/avextra.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/avextra-ag\/","https:\/\/www.xing.com\/pages\/avextra"]},{"@type":"Person","@id":"https:\/\/avextra.com\/#\/schema\/person\/aa74df4160383edd63d06428edfecd0b","name":"Torsten Meyer-Bautor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/avextra.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b9ef8b21e6c420b5e45a3e65c39ed5b9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b9ef8b21e6c420b5e45a3e65c39ed5b9?s=96&d=mm&r=g","caption":"Torsten Meyer-Bautor"}}]}},"author_meta":{"display_name":"Torsten Meyer-Bautor","author_link":"https:\/\/avextra.com\/en\/author\/tmeyer-bautor\/"},"featured_img":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/09\/Vorschaubild_Pressemitteilung_Switzerland-Austria-300x236.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/avextra.com\/en\/category\/deutsch\/\" class=\"advgb-post-tax-term\">deutsch<\/a>","<a href=\"https:\/\/avextra.com\/en\/category\/english\/\" class=\"advgb-post-tax-term\">english<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">deutsch<\/span>","<span class=\"advgb-post-tax-term\">english<\/span>"]}},"comment_count":0,"relative_dates":{"created":"Posted 3 years ago","modified":"Updated 3 years ago"},"absolute_dates":{"created":"Posted on 15. September 2023","modified":"Updated on 15. September 2023"},"absolute_dates_time":{"created":"Posted on 15. September 2023 12:50","modified":"Updated on 15. September 2023 12:59"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/posts\/3742"}],"collection":[{"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/comments?post=3742"}],"version-history":[{"count":2,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/posts\/3742\/revisions"}],"predecessor-version":[{"id":3744,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/posts\/3742\/revisions\/3744"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/media\/3741"}],"wp:attachment":[{"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/media?parent=3742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/categories?post=3742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avextra.com\/en\/wp-json\/wp\/v2\/tags?post=3742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}